These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
296 related articles for article (PubMed ID: 2491955)
1. Induction of terminal differentiation-resistant epidermal cells in mouse skin and in papillomas by different initiators during two-stage carcinogenesis. Miller DR; Viaje A; Rotstein J; Aldaz CM; Conti CJ; Slaga TJ Cancer Res; 1989 Jan; 49(2):410-4. PubMed ID: 2491955 [TBL] [Abstract][Full Text] [Related]
3. Tumor progression in Sencar mouse skin as a function of initiator dose and promoter dose, duration, and type. Ewing MW; Conti CJ; Kruszewski FH; Slaga TJ; DiGiovanni J Cancer Res; 1988 Dec; 48(24 Pt 1):7048-54. PubMed ID: 3142681 [TBL] [Abstract][Full Text] [Related]
4. Comparison of two-stage epidermal carcinogenesis initiated by 7,12-dimethylbenz(a)anthracene or N-methyl-N'-nitro-N-nitrosoguanidine in newborn and adult SENCAR and BALB/c mice. Hennings H; Devor D; Wenk ML; Slaga TJ; Former B; Colburn NH; Bowden GT; Elgjo K; Yuspa SH Cancer Res; 1981 Mar; 41(3):773-9. PubMed ID: 6780187 [TBL] [Abstract][Full Text] [Related]
5. Squamous cell hyperplastic foci: precursors of cutaneous papillomas induced in SENCAR mice by a two-stage carcinogenesis regimen. Binder RL; Johnson GR; Gallagher PM; Stockman SL; Sundberg JP; Conti CJ Cancer Res; 1998 Oct; 58(19):4314-23. PubMed ID: 9766659 [TBL] [Abstract][Full Text] [Related]
6. Development of an in vitro model to study carcinogen-induced neoplastic progression of initiated mouse epidermal cells. Morgan D; Welty D; Glick A; Greenhalgh D; Hennings H; Yuspa SH Cancer Res; 1992 Jun; 52(11):3145-56. PubMed ID: 1375535 [TBL] [Abstract][Full Text] [Related]
7. NTP Comparative Initiation/Promotion Skin Paint Studies of B6C3F1 Mice, Swiss (CD-1(R)) Mice, and SENCAR Mice. National Toxicology Program Natl Toxicol Program Tech Rep Ser; 1996 Feb; 441():1-201. PubMed ID: 12595922 [TBL] [Abstract][Full Text] [Related]
8. NTP Initiation/Promotion Study of o-Benzyl-p-Chlorophenol (CAS No. 120-32-1) in Swiss (CD-1(R)) Mice (Mouse Skin Study). National Toxicology Program Natl Toxicol Program Tech Rep Ser; 1995 May; 444():1-136. PubMed ID: 12595919 [TBL] [Abstract][Full Text] [Related]
9. Frequent codon 12 Ki-ras mutations in mouse skin tumors initiated by N-methyl-N'-nitro-N-nitrosoguanidine and promoted by mezerein. Rehman I; Lowry DT; Adams C; Abdel-Fattah R; Holly A; Yuspa SH; Hennings H Mol Carcinog; 2000 Apr; 27(4):298-307. PubMed ID: 10747294 [TBL] [Abstract][Full Text] [Related]
10. A course of very small doses of DMBA, each of them allegedly with no promoting potency, acts with clear synergistic effect as a strong promoter of DMBA-initiated mouse skin carcinogenesis. A comparison of the tumorigenic and carcinogenic effects of DMBA (7,12-dimethylbenz-alpha-anthracene) and TPA (12-O-tetradecanoyl-phorbol-13-acetate) used as initiators and promoters in classical two-stage experimental protocols. Iversen OH APMIS Suppl; 1994; 41():1-38. PubMed ID: 7946481 [TBL] [Abstract][Full Text] [Related]
11. NTP Toxicology and Carcinogenesis Studies of Diethylphthalate (CAS No. 84-66-2) in F344/N Rats and B6C3F1 Mice (Dermal Studies) with Dermal Initiation/ Promotion Study of Diethylphthalate and Dimethylphthalate (CAS No. 131-11-3) in Male Swiss (CD-1(R)) Mice. National Toxicology Program Natl Toxicol Program Tech Rep Ser; 1995 May; 429():1-286. PubMed ID: 12616302 [TBL] [Abstract][Full Text] [Related]
12. Genetic alterations cooperate with v-Ha-ras to accelerate multistage carcinogenesis in TG.AC transgenic mouse skin. Owens DM; Spalding JW; Tennant RW; Smart RC Cancer Res; 1995 Jul; 55(14):3171-8. PubMed ID: 7606738 [TBL] [Abstract][Full Text] [Related]
13. Papilloma development is delayed in osteopontin-null mice: implicating an antiapoptosis role for osteopontin. Hsieh YH; Juliana MM; Hicks PH; Feng G; Elmets C; Liaw L; Chang PL Cancer Res; 2006 Jul; 66(14):7119-27. PubMed ID: 16849558 [TBL] [Abstract][Full Text] [Related]
14. Evidence for a new model of tumor progression from carcinogenesis and tumor promotion studies with 7-bromomethylbenz[a]anthracene. Scribner JD; Scribner NK; McKnight B; Mottet NK Cancer Res; 1983 May; 43(5):2034-41. PubMed ID: 6403231 [TBL] [Abstract][Full Text] [Related]
15. Only a subset of 12-O-tetradecanoylphorbol-13-acetate-promoted mouse skin papillomas are promotable by benzoyl peroxide. Mancuso M; Pazzaglia S; Tanori M; Rebessi S; Di Majo V; Covelli V; Saran A Mutat Res; 2004 Apr; 548(1-2):35-45. PubMed ID: 15063134 [TBL] [Abstract][Full Text] [Related]
16. Characterization of skin tumor promotion and progression by chrysarobin in SENCAR mice. Kruszewski FH; Conti CJ; DiGiovanni J Cancer Res; 1987 Jul; 47(14):3783-90. PubMed ID: 3109733 [TBL] [Abstract][Full Text] [Related]
17. A model for initiated mouse skin: suppression of papilloma but not carcinoma formation by normal epidermal cells in grafts on athymic nude mice. Strickland JE; Ueda M; Hennings H; Yuspa SH Cancer Res; 1992 Mar; 52(6):1439-44. PubMed ID: 1540951 [TBL] [Abstract][Full Text] [Related]
18. Association of resistance to terminal differentiation with initiation of carcinogenesis in adult mouse epidermal cells. Kawamura H; Strickland JE; Yuspa SH Cancer Res; 1985 Jun; 45(6):2748-52. PubMed ID: 3921248 [TBL] [Abstract][Full Text] [Related]
19. Dissociation of sensitivities to tumor promotion and progression in outbred and inbred SENCAR mice. Gimenez-Conti IB; Bianchi AB; Fischer SM; Reiners JJ; Conti CJ; Slaga TJ Cancer Res; 1992 Jun; 52(12):3432-5. PubMed ID: 1375869 [TBL] [Abstract][Full Text] [Related]
20. Promoter independence as a feature of most skin papillomas in SENCAR mice. Aldaz CM; Conti CJ; Chen A; Bianchi A; Walker SB; DiGiovanni J Cancer Res; 1991 Feb; 51(3):1045-50. PubMed ID: 1899044 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]